Cellular Therapy for Autoimmune Disease: Developments in Immunology
Editat de Samik Basu, Jinmin Leeen Limba Engleză Paperback – mar 2027
Finally, the book addresses unique clinical and manufacturing considerations, offering a roadmap for the future state of cellular therapies in autoimmune diseases. This essential resource addresses the rapid advancements in cell therapies that have outpaced the availability of integrated, up-to-date resources. By bridging the gap between scientific research and clinical applications, it offers in-depth insights into mechanisms of action, disease-specific therapeutic strategies, and the latest innovations in clinical and manufacturing considerations for scientists and clinicians.
- Bridges the gap between scientific research and clinical applications for cellular therapies in autoimmune diseases
- Offers in-depth insights into mechanisms of action and disease-specific therapeutic strategies
- Addresses key clinical and manufacturing challenges for developing and implementing cell-based therapies
- Integrates the latest scientific discoveries and clinical breakthroughs for comprehensive understanding
- Equips professionals with practical knowledge to accelerate the translation of therapies into clinical practice
Preț: 903.32 lei
Preț vechi: 950.86 lei
-5% Precomandă
Puncte Express: 1355
Carte nepublicată încă
Livrare prin curier în România Precomanda se expediază când titlul devine disponibil.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Specificații
ISBN-13: 9780443439780
ISBN-10: 0443439788
Pagini: 250
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Seria Developments in Immunology
ISBN-10: 0443439788
Pagini: 250
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Seria Developments in Immunology
Cuprins
1. How the standard of care for autoimmune diseases has evolved from chronic suppression to that of targeted replacement or suppression
2. Autologous Regulatory T-cell (Treg) approaches for autoimmune disease
3. Autologous Effector T-cell approaches for autoimmune disease. Part I, Antigen Specific Approaches
4. Autologous Effector T-cell approaches for autoimmune disease. Part II, Pan B-cell Depletion Approaches
5. Autologous Effector T-cell approaches for autoimmune disease. Part III, Pan Plasma Cell Depletion Approaches
6. Myeloid Cellular Approaches for Autoimmune Disease
7. Allogeneic Cellular Approaches for Autoimmune Disease
8. Viral or Nanoparticle-Based Approaches for Autoimmune Disease
9. Unique Clinical Considerations for Cellular Therapies for Autoimmune Disease
10. Unique Manufacturing Considerations for Cellular Therapies for Autoimmune Disease
11. Global Perspectives. Regulatory, Ethical, and Cultural Dimensions of Cellular Therapies
12. Future Directions and Challenges for Cellular Therapies in Autoimmune Disease
2. Autologous Regulatory T-cell (Treg) approaches for autoimmune disease
3. Autologous Effector T-cell approaches for autoimmune disease. Part I, Antigen Specific Approaches
4. Autologous Effector T-cell approaches for autoimmune disease. Part II, Pan B-cell Depletion Approaches
5. Autologous Effector T-cell approaches for autoimmune disease. Part III, Pan Plasma Cell Depletion Approaches
6. Myeloid Cellular Approaches for Autoimmune Disease
7. Allogeneic Cellular Approaches for Autoimmune Disease
8. Viral or Nanoparticle-Based Approaches for Autoimmune Disease
9. Unique Clinical Considerations for Cellular Therapies for Autoimmune Disease
10. Unique Manufacturing Considerations for Cellular Therapies for Autoimmune Disease
11. Global Perspectives. Regulatory, Ethical, and Cultural Dimensions of Cellular Therapies
12. Future Directions and Challenges for Cellular Therapies in Autoimmune Disease